Integrative Multi-Omics and Artificial Intelligence: A New Paradigm for Systems Biology

The increasing accessibility of high-throughput omics technologies has represented a paradigm change in systems biology, facilitating the systematic exploration of biological complexity at genomic, transcriptomic, proteomic, and metabolomic levels. Contemporary systems biology more and more depends on integrative multi-omics strategies to unravel the sophisticated, dynamic networks of cellular function and organismal phenotypes. Such methodologies enable scientists to clarify molecular interactions, decipher disease pathology, identify strong biomarkers, and guide precision medicine and synthetic biology initiatives. Recent technological breakthroughs in computational tools, ranging from early or late data integration, network analysis, and machine learning, have overcome obstacles of high-dimensionality, heterogeneity, and perturbations restricted to specific contexts. In this review, we critically assess the principles, methods, and applications of multi-omics integration, with an emphasis on cancer biology, microbial engineering, and synthetic biology. We showcase case studies in which integrative omics provided actionable findings. Finally, we address current limitations (e.g., data heterogeneity, interpretability) and forthcoming solutions (artificial intelligence, single-cell omics, cloud platforms). By closing the gap between molecular layers, multi-omics integration is moving toward predictive models of biological systems and revolutionary biotechnological applications.